Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 2, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. - The lawsuit claims that Molina failed to disclose several material adverse facts regarding its financial health, which misled investors [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a record settlement against a Chinese company and significant recoveries for investors in recent years [4]. Group 3: Case Specifics - The lawsuit alleges that Molina's management misrepresented the company's medical cost trend assumptions and financial guidance for fiscal year 2025, leading to investor damages when the true information was revealed [5].

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Ltd. for allegedly misleading investors during the Class Period from April 21, 2023, to April 30, 2025, with a deadline for lead plaintiff applications set for January 20, 2026 [2][6]. Group 1: Lawsuit Details - The lawsuit claims that Jayud was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [6]. - It is alleged that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign [6]. - The company's public statements and risk disclosures reportedly failed to mention the false rumors and artificial trading activity affecting the stock price, leading to materially misleading statements about its business and prospects [6]. Group 2: Investor Guidance - Investors who purchased Jayud securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of James Hardie Industries plc to secure legal counsel before the December 23, 2025 deadline for a securities class action lawsuit related to misleading statements about the company's performance during a specific period [2][4]. Group 1: Class Action Details - The class action pertains to investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, and may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A lawsuit claims that James Hardie misled investors regarding the strength of its North America Fiber Cement segment, falsely asserting that demand was strong while distributors were actually destocking inventory [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. who experienced losses exceeding $100,000 during the specified Class Period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The Class Period for the Cepton, Inc. securities class action is from July 29, 2024, to January 6, 2025 [1]. - Investors who purchased or sold Cepton common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Allegations Against Cepton - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, particularly concerning a third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - It is claimed that Cepton's Board of Directors failed to adequately explore this offer and did not disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Telix Pharmaceuticals Ltd. to secure legal counsel before the January 9, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from February 21, 2025 to August 28, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Telix securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 9, 2026 [3]. - The lawsuit alleges that Telix made materially false and misleading statements regarding its prostate cancer therapeutic candidates and the quality of its supply chain, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of the Plaintiffs' Bar in 2020 [4].

Core Insights - Bitzero Holdings Inc. will commence trading on the Canadian Securities Exchange under the ticker symbol "BITZ.U" starting November 24, 2025, marking a significant milestone for the company during a bullish phase in the cryptocurrency market [1][2]. Company Overview - Bitzero focuses on sustainable blockchain and high-performance computing data centers, emphasizing low-cost operations and aggressive infrastructure expansion to meet increasing market demand [2][3]. - The company operates four data centers located in Norway, Finland, and the U.S., with a combined energy capacity exceeding 1GW, utilizing clean and sustainable energy sources [2][11]. Financial Metrics - Bitzero's energy cost for cryptocurrency mining is approximately US$0.04 per kWh, with an all-in breakeven cost of US$56,000 and a mining efficiency of 20 joules per terahash [2]. - For October 2025, Bitzero reported a gross profit of US$71,034 per day and a monthly gross profit of US$2,131,035, resulting in a mining margin of 46.24% [6][18]. Production Metrics - In October 2025, Bitzero's total hash rate was 1.84 EH/s, with 23.47 Bitcoins mined, a slight decrease from 23.85 Bitcoins in September 2025 [7][9]. - The company sold 27 Bitcoins in October, representing 95% of its production for the month, compared to 79% in September [9]. Investment and Market Position - Bitzero has attracted over US$100 million in investments, including contributions from notable investors like Kevin O'Leary, who emphasizes the importance of investing in both Bitcoin and the infrastructure that supports it [3][4].

Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics to secure legal counsel before the December 15, 2025 deadline for a securities class action related to the company's stock performance during the specified class period [2][3]. Group 1: Class Action Details - Investors who purchased common stock of MoonLake between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The deadline to move the court to serve as lead plaintiff is December 15, 2025, with the lead plaintiff acting on behalf of other class members [4]. Group 2: Legal Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [5]. Group 3: Case Allegations - The complaint alleges that during the class period, defendants made false or misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information [1] Group 1: Investigation and Allegations - Nidec Corporation is facing scrutiny after a report indicated improper accounting practices within its China unit, leading to a significant drop in share prices [3] - Following the announcement of the probe, Nidec's American Depositary Receipts (ADRs) experienced a decline of 22.7% on September 4, 2025, marking the largest one-day drop for the company [3] Group 2: Class Action Details - Shareholders who purchased Nidec Corporation securities may be eligible for compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the law firm directly for more information [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4] - The firm has consistently ranked among the top in securities class action settlements, recovering hundreds of millions for investors, including over $438 million in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Zions Bancorporation due to allegations of materially misleading business information issued by the company [1] Group 1: Legal Action and Investor Rights - Shareholders who purchased Zions Bancorporation securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to the alleged misleading information [2] Group 2: Financial Impact and Company Disclosure - On October 15, 2025, Zions Bancorporation announced a $50 million charge-off for a loan due to misrepresentations and contractual defaults by borrowers [3] - Following this announcement, Zions Bancorporation's common stock experienced a decline of 13.14% on October 16, 2025 [4] Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [5] - The firm has been recognized as a leader in the field, being ranked No. 1 for securities class action settlements in 2017 and consistently in the top 4 since 2013 [5]